Editorial Office
Editor-in-Chief
Prof. Dr. Robert H. Weiss
Division of Nephrology and Cancer Center, University of California, Davis, CA 95616, USA; and Nephrology Section, Sacramento VAMC; and NCI Early Detection Research Network (EDRN), USA
Tel. +1 530 752 4010; Fax: +1 530 752 3791
E-Mail:
Interests: cyclins and cyclin inhibitors; cancer growth control; metabolomics and proteomics; polycystic kidney disease
Managing Editor
Ms. Candy Wan
MDPI Beijing Office, Liyuanbeijie Road 186, Suite 307, Liyuan Town, Tongzhou District, 101101 Beijing, China
Tel. +86 10 59011009; Fax: +86 10 59011089
E-Mail:
Production Editor
Dr. Brietta Pike
MDPI AG, Postfach, CH-4005 Basel, Switzerland. Office: Kandererstrasse 25, 4057 Basel
Tel. +41 61 683 77 34; Fax: +41 61 302 89 18
E-Mail:
Publisher
Dr. Shu-Kun Lin
MDPI AG, Postfach, CH-4005 Basel, Switzerland. Office: Kandererstrasse 25, 4057 Basel
Tel. +41 61 683 77 34; Fax: +41 61 302 89 18
Website: http://www.mdpi.org/lin/
E-Mail:
Editorial Board
Dr. Robert A. Anders
Johns Hopkins School of Medicine, Department of Pathology, Division of GI & Liver Pathology, 1550 Orleans St., Cancer Research Building II Rm 346, Baltimore, Maryland 21231, USA
Tel. +1 410 955 3511; Fax: +1 410 614 0671
Website: http://pathology.jhu.edu/researchbrochure/division.cfm?id=6&#Anders
E-Mail:
Interests: liver cancer; hepatitis; bile duct cancer; bile duct development; human liver pathology
Dr. Brigitta G. Baumert
Department of Radiation-Oncology (MAASTRO), Maastricht University, Medical Centre and GROW Research Institute, The Netherlands
Tel. +31 88 44 55 666 / 600; Fax: +31 88 44 55 667
Website: http://www.maastro.nl/
E-Mail:
Interests: CNS tumors; sarcomas; pet imaging; new MRI imaging techniques introduced for radiation therapy; new international trials in primaruy and secondary brain tumors
Contribution:
Special Issue: Cancer Cell Imaging
Special Issue: Re-Irradiation, Chemotherapy, New Drugs for the (Re)-Treatment of Recurrent Gliomas
Dr. Don Benjamin
Growth & Development Unit, Rm. 583 Biozentrum, University of Basel, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland
Tel. +41 61 267 21 70; Fax: +41 61 267 07 59
E-Mail:
Interests: mTOR; cancer metabolism; glycolysis; signal transduction; mRNA stability
Contribution:
Special Issue: Cancer Signaling Pathways and Crosstalk
Dr. William Chi-shing Cho
Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong
Tel. +852 2958 5441; Fax: +852 2958 5455
E-Mail:
Interests: microRNA; cancer biomarker; non-small cell lung carcinoma, nasopharyngeal carcinoma; SELDI
Contribution:
In other journals:
Special Issue: Advances in Molecular Oncology
Dr. Jonas Cicenas
Laboratory for Molecular Medicine and Hematology, Department of, Clinical Research, Inselspital Bern, MEM D821, Murtenstrasse 35, CH-3010, Bern, Switzerland
Tel. +41 31 632 09 55; Fax: +41 31 632 32 97
Website: http://mapk.8m.com/Founder
E-Mail:
Interests: breast cancer; ErbB2; Akt; signal transduction; acute myeloid leukemia (AML); regulation of transcription; PU.1
Prof. Dr. Robert Coleman
Yorkshire Cancer Research, Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, S10 2SJ, UK
Tel. +44 114 226 5213; Fax: +44 114 226 5364
Website: http://www.sheffield.ac.uk/medicine/oncology/staffprofiles/coleman.html
E-Mail:
Interests: cancer induced bone disease especially with relevance to breast cancer; the development of bone targeted agents in oncology, evaluation of bone markers in oncology to aid drug development and provide both prognostic and predictive information in the management of metastatic bone disease, and the assessment of adverse effects of cancer treatments on bone health and evaluation of various treatment strategies
Dr. Philipp Dahm
Clinical Research, Department of Urology, University of Florida, College of Medicine, Health Science Center, Box 100247, Room N2-15, Gainesville, FL 32610-0247, USA
Tel. +1 352 273 7647; Fax: +1 352 273 7515
Website: http://urology.ufl.edu/bio_PhilippDahm.php
E-Mail:
Interests: prostate cancer; kidney cancer; bladder cancer; evidence based clinical practice; guideline development; research methodology
Prof. Dr. Ronald A. DePinho
1 Department of Medicine, Harvard Medical School, Boston, MA 02115, USA
2 Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA
Tel. +1-617-632-6086; Fax: +1-617-632-6069
Website: http://www.dfhcc.harvard.edu/membership/profile/member/107/0/
E-Mail:
Interests: our research focuses on mechanisms governing normal development and aging and cancer pathogenesis. Significant effort is devoted towards construction of mouse models of human cancer, particularly melanoma, prostate, and brain.
Dr. Guillermo Velasco Díez
Department of Biochemistry and Molecular Biology I, Complutense University, Madrid, Spain
Tel. +34 913944668; Fax: +34 913944672
E-Mail:
Interests: autophagy; ER stress; gliomas; cannabinoid antitumoral action; ceramide signaling
Dr. Serenella Eppenberger-Castori
Stiftung Tumorbank Basel, Tumorbank Foundation Basel, Lörracherstr. 50, CH-4125 Riehen, Switzerland
Tel. +41 61 6459304; Fax: +41 61 6459308
E-Mail:
Interests: breast cancer; molecular cancer pathology; prognosis and prediction; bioinformatics and statistics; translational research
Dr. Doriano Fabbro
Department of Pharmaceutical Research, Therapeutic Area: Oncology/Hematology, Unit: Biology I (In Vitro Lead Profiling) K-125-4.10, Pharmaceutical Research, Novartis, CH-4002 Basel, Switzerland
Tel. +41 (0)61 696 76 81 or +41 (0)61 696 13 03; Fax: +41 (0)61 696 38 35
E-Mail:
Interests: protein kinases regulation; structure; screening and drug discovery
Dr. Salvador Villà Freixa
Department of Radiation Oncology, Hospital Universitari Germans Trías, ICO Badalona, C/Canyet s/n, 08916 Badalona, Catalunya, Spain
E-Mail:
Interests: CNS tumours; prostate cancer; sterotactic RT
Dr. Samy L. Habib
1 Department of Cellular and Structural Biology, The University of Texas Health Science Center, San Antonio, TX, USA
2 Geriatric Research, Education and Clinical CTR, South Texas veterans Health System, San Antonio, TX, 78229, USA
Tel. +1 210 567 3816; Fax: +1 210 567 3802
Website: http://www.uthscsa.edu/csb/faculty/habib.asp
E-Mail:
Interests: tumor supressor genes; DNA damage and repair pathways; diabetes and cancer; kidney and liver cancer; cell signaling; apoptosis and proliferation; cancer biomakers
Prof. Dr. Jörg Haier
Comprehensive Cancer Center Muenster, International Patient Management, University Hospital Muenster, Waldeyerstr. 1, 48149 Muenster, Germany
Tel. +49 251 83 57630 (Labor 56326); Fax: +49 251 83 57631
Website: http://cccm.uni-muenster.de/
E-Mail:
Interests: gastraintestinal cancer; metastasis; cell adhesion; cell migration; chemotaxis
Contribution:
Special Issue: Epigenetics of Cancer Progression
Special Issue: Organ-Specific Metastasis Formation
Prof. Dr. Carl-Henrik Heldin
Ludwig Institute for Cancer Research, Box 595, Biomedical Center, S-751 24 Uppsala, Sweden
Tel. +46 18 160401; Fax: +46 18 160420
Website: http://www.licr.uu.se/B_about/
E-Mail:
Interests: growth factors; signal transduction mechanisms; receptors; kinases; angiogenesis
Prof. Dr. W. Martin Kast
Walter A. Richter Cancer Research Chair, Professor of Molecular Microbiology & Immunology, Obstetrics & Gynecology and Urology, Norris Comprehensive Cancer Center (NRT 7507), University of Southern California, 1450 Biggy Street, MC 9601, Los Angeles, CA90033, USA
Tel. +1 323 442 3870; Fax: +1 323 442 7760
Website: http://www.usc.edu/programs/pibbs/site/faculty/kast_w.htm
E-Mail:
Interests: design of HPV immunotherapeutics; developing new and effective therapies for cervical cancer; prostate cancer and melanoma
Contribution:
Special Issue: Cancer Vaccines and Immunotherapy
Dr. Charles H. Lawrie
Lymphoid Malignancy Research Group, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK
Tel. +44 1865 220344
Website: http://www.ndcls.ox.ac.uk/ResGroups.php?GID=29
E-Mail:
Interests: cancer; lymphoma; leukemia; microarray; microRNA; biomarkers; non-coding RNA
Contribution:
Special Issue: Leukemia
Dr. Chyi-Chia Richard Lee
Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 2B50, 9000 Rockville Pike, Bethesda, MD 20892-0001, USA
Tel. +1 301 594 7365; Fax: +1 301 480 9488
Website: http://ccr.cancer.gov/staff/staff.asp?profileid=12822
E-Mail:
Interests: melanoma; skin cancers; dermatopathology; skin pathology; melanocytic skin lesions
Contribution:
Special Issue: Current Concepts in the Diagnosis and Treatment of Cutaneous Melanoma
Dr. Alessandro Lugli
Institute of Pathology, University of Bern, 3010 Bern, Switzerland
Tel. +41 31 632 99 58; Fax: +41 31 632 49 95
E-Mail:
Interests: gastrointestinal and liver tumors; tumor diagnosis and staging; prognostic and predictive biomarkers
Contribution:
Special Issue: Prognostic and Predictive Factors in Colorectal Cancer
Dr. Sauveur-Michel Maira
DD2, NIBR Oncology, WKL-125.1.08, Novartis Pharma AG, Klybeckstrasse 141, CH-4057 Basel, Switzerland
Tel. +41 61 6967910; Fax: +41 61 6965751
E-Mail:
Interests: drug discovery; small molecule inhibitors; signaling pathways; predictive biomarkers; response biomarkers
Prof. Dr. Dario Marchetti
Department of Pathology & Immunology, and Department of Molecular & Cellular Biology, Circulating Tumor Cells (CTC) Core Facility, Baylor College of Medicine, Houston, TX 77030, USA
Tel. +1 713 798 2335; Fax: +1 713 798 1956
Website: http://www.bcm.edu/mcb/index.cfm?pmid=8866
E-Mail:
Interests: mechanisms of brain metastasis; the biology and therapeutic utility of circulating tumor cells (CTCs); the roles of heparanase in development and disease
Dr. Enrique A. Mesri
Viral Oncology Research Program, Department of Microbiology and Immunology, Sylvester Comprehensive Cancer Center, University of Miami, School of Medicine, 1550 NW 10th Ave, PAP bldg Ste 109B (R138) Miami, FL 33136, USA
Tel. +1 305 243 5659; Fax: +1 305 243 8309
Website: http://chroma.med.miami.edu/micro/faculty_mesri.html
E-Mail:
Interests: molecular mechanisms of viral oncogenesis of Kaposi\'s sarcoma; KSHV and AIDS-associated malignancies with an emphasis in translational cancer research; cell signaling, angiogenesis and genomics
Prof. Dr. Alba Minelli
Cellular Biochemistry Unit, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Via del Giochetto, 06124, Perugia, Italy
Tel. +39 075 7440; Fax: +39 075 7442
E-Mail:
Interests: prostate cancer; oxidative stress; prostasomes; adenosine
Contribution:
Special Issue: Oxidative Stress and Cancer
Dr. Constantine S. Mitsiades
Department of Medical Oncology, Dana-Farber Cancer Institute; and Department of Medicine, Harvard Medical School, 44 Binney Street, Mayer Building, Room M555, Boston, MA 02115, USA
Tel. +1 617 632 1962; Fax: +1 617 812 7701
Website: http://www.dfhcc.harvard.edu/membership/profile/member/485/0/
E-Mail:
Interests: hematologic malignancies; novel therapeutics; signal transduction inhibitors; tumor microenvironment; bone metastases; clinical trial design; prognostic markers; multiple myeloma; plasma cell dyscrasias; insulin-like growth factor; IGF1R; heat shock protein; proteasome; histone deacetylase; kinase
Contribution:
Special Issue: Tumor Cell Genesis and Its Microenvironment: Chicken or the Egg
Dr. Margareta Mueller
Group Tumor and Microenvironment, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Tel. +49 6221 424533; Fax: +49 6221 424551
E-Mail:
Interests: tumor stroma interaction; angiogenesis; inflammation and cancer; growth factors and cytokines; proteases; IL-6 signalling
Contribution:
Special Issue: Tumor Cell Genesis and Its Microenvironment: Chicken or the Egg
Prof. Dr. Hasan Mukhtar
Department of Dermatology, University of Wisconsin, Medical Science Center, Rm 4385, 1300 University Avenue, Madison, WI 53706,USA
Tel. +1-608 263 3927; Fax: +1-608 263 5223
Website: http://metc.med.wisc.edu/metc/fac/fac33.php
E-Mail:
Interests: apoptosis; chemical carcinogenesis; chemoprevention, cytochrome P450; metabolic basis of toxicity; photocarcinogenesis; tumor promotion/prevention
Prof. Dr. Akira Nakagawara
Chiba Cancer Center, Director of Research Institute; and Division of Biochemistry and Innovative Cancer Therapeutics, 666-2 Nitona, Chuo-ku, Chiba 260-8717, Japan
Tel. +81 43 264 5431; Fax: +81 43 263 8175
Website: http://www.chiba-cc.jp/en/inst/index.html
E-Mail:
Interests: molecular biology of cancer; neuroblastoma and neural development
Prof. Dr. Masanobu Oshima
Division of Genetics, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan
Tel. +81-76-264-6760; Fax: +81-76-234-4519
E-Mail:
Interests: cancer genetics; molecular pathology of gastrointestinal cancers; cancer stem cell and Wnt signaling
Contribution:
Special Issue: Exploring Inflammation in Cancers
Dr. Diane Palmieri
Women’s Cancer Section, Laboratory of Molecular Pharmacology, National Cancer Institute, 37 Convent Drive, MSC 4254, Building 37, Rm. 1126, Bethesda, MD 20892, USA
Tel. +1 301 594 0685; Fax: +1 301 402 8910
Website: http://ccr.cancer.gov/staff/staff.asp?profileid=8096
E-Mail:
Interests: metastasis, breast cancer; metastasis suppressor genes
Dr. George Pentheroudakis
Medical Oncologist, Department of Medical Oncology, Ioannina University Hospital, Greece
E-Mail:
Interests: GI cancer; cancer of unknown primary; cancer and pregnancy; adolescent/young adult oncology and phase I/pharmacokinetic studies of investigational agents
Prof. Dr. Sven Perner
Institute of Pathology, University Hospital of Bonn, Sigmund-Freud-Str. 25, 53127 Bonn, Germany
Tel. +49 228 287 15323; Fax: +49 228 287 9080019
Website: http://www.pernerlab.de/mitarbeiter/sven_perner.htm
E-Mail:
Interests: understanding of the molecular biology of prostate cancer and the development of predictive biomarkers; genetics; molecular biology; TMPRSS2-ERG gene fusion; gene translocations; biomarker development
Contribution:
Special Issue: Prostate Cancer
Dr. Christian Pilarsky
Klinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany
Tel. +49 351 458 166 07; Fax: +49 351 449 210 303
Website: http://vtg.uniklinikum-dresden.de/Pankreaslabor/
E-Mail:
Interests: pancreas cancer; apoptosis; microarrays; signal transduction networks; tumor stroma interaction; prostate cancer; biomarker
Contribution:
Special Issue: Pancreatic Cancer
Prof. Dr. Dirk Rades
Department of Radiation Oncology, University of Lübeck, UK-SH Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany
Tel. +49 451 5006661; Fax: +49 451 5003324
Website: http://www.strahlentherapie-lübeck.de/
E-Mail:
Interests: radiation oncology; metastases; radiochemotherapy; CNS tumors; head and neck cancer; gastrointestinal cancer
Dr. Michael W. Retsky
1 Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
2 Adjoint Professor, Universidad Autonoma de Nuevo Leon (UANL) Center for Research and Health Science Development in Monterrey, Mexico
Tel. +1 203 675 0017
Website: http://connects.catalyst.harvard.edu/PROFILES/ProfileDetails.aspx?Person=MWR2
E-Mail:
Interests: cancer research; electron beam technology
Contribution:
Special Issue: Surgery Induced Tumorigenesis in Breast and Other Cancers: An Inconvenient Truth?
In other journals:
Special Issue: Neural Networks and Sensors
Special Issue: Neural Networks and Sensors
Prof. Dr. Afshin Samali
Head of Biochemistry, School of Natural Sciences, National University of Ireland - Galway, University Road, Galway, Ireland
Tel. +353 91 492440; Fax: +353 91 494596
Website: http://www.nuigalway.ie/biochemistry/staff/samali/index.html
E-Mail:
Interests: apoptosis; cell death; autophagy; TRAIL; heat shock proteins; Endoplasmic Reticulum stress; hypoxia
Contribution:
Special Issue: Cell Death and Cancer
Dr. Thomas D. Schmittgen
Division of Pharmaceutics, College of Pharmacy, Ohio State University, Parks Hall, 500 West 12th Avenue, Columbus, OH 43210, USA
Tel. +1 614 292 3456; Fax: +1 614 292 7766
Website: http://www.pharmacy.ohio-state.edu/programs/ceut/faculty/schmittgen/
E-Mail:
Interests: noncoding RNA; microRNA; cancer; quantitative RT-PCR; pancreatic cancer
Prof. Dr. Sandip Kumar SenGupta
Clinical Laboratory Services, KGH, HDH, and Perth & Smiths Falls District Hospital; and Department of Pathology & Molecular Medicine; and Professor of Pathology, Queen\'s University, Canada
Tel. +1 613 549 6666 x4169; Fax: +1 613 548 6076
E-Mail:
Interests: breast cancer pathology; immunohistochemistry; prognostic and predictive factors
Dr. Giulio C. Spagnoli
Laboratory of Oncology, Institute of Surgical Research and Hospital Management, University of Basel, c/o ZLF, Hebelstrasse 20, CH-4031 Basel, Switzerland
Tel. +1 (0)61 265 2378
Website: http://biomedizin.unibas.ch/nc/about-us/people/profil/profile/person/spagnoli/
E-Mail:
Interests: tumor immunology; cellular immunology; cancer cell biology
Dr. Eike Staub
Drug Discovery Informatics, Merck Serono Research & Development, Merck KGaA, Darmstadt, Germany
Tel. +49 6151 725989; Fax: +49 6151 723329
E-Mail:
Interests: cancer drug target identification and validation; cancer drug discovery; oncogenomics for preclinical models & for patient stratification; bioinformatics for prediction of disease genes; analysis of protein, gene and genome evolution
Dr. Tomoharu Sugie
Breast Surgery, Kyoto University Hospital, 54 Shogoin Kawara-cho, Sakyo-ku, Kyoto 606-8507, Japan
Tel. +81 75 751 3660; Fax: +81 75 751 3616
E-Mail:
Interests: breast surgery; cancer immunology
Contribution:
Special Issue: Breast Cancer
Dr. Ugo Testa
Medical Oncology Section, Department of Hematology and Oncology, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
Tel. +39 06 4990 2422
Website: http://www.iss.it/site/attivita/ISSWEB_istituto/RicercaPersonale/dettaglio.asp?idAna=1239&lang=1
E-Mail:
Dr. Kwong Yok Tsang
Cellular Immunology Group, Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, MSC-1750, Building 10, Room 8B08, Bethesda, MD 20892, USA
Tel. +1 301 496 9694; Fax: +1 301 496 2756
Website: http://ccr.cancer.gov/Labs/Lab.asp?LabID=39
E-Mail:
Interests: the role of the human immune response to tumor-associated antigens. We are working to define and develop immunodominant determinants and modifications of those determinants toward the optimal activation of human immune responses to tumor-associated antigens. Additionally, we are involved in studying mechanisms to enhance the potency of antigen-presenting cells for specific T cell activation. We are also developing immunologic methods and immunoassays to better define the efficacy of vaccine therapies for a range of human cancers.
Contribution:
Special Issue: Immune Responses to Human Prostate Cancer
Dr. Asad Umar
Gastrointestinal & Other Cancers Research Group, Division of Cancer Prevention, National Cancer Institute, 6130 Executive Blvd, EPN2142, Rockville, MD 20852, USA
Tel. +1 301 594 2684; Fax: +1 301 435 6344
E-Mail:
Interests: gastrointestinal; skin, and hematolymphoid cancers prevention policies and future research directions
Prof. Dr. Xiao Yan Zhong
Department of Biomedicine, University Hospital Basel, Hebelstrasse 20, CH-4031 Basel, Switzerland
Tel. +41 61 328 69 86
Website: http://biomedizin.unibas.ch/nc/about-us/people/profil/profile/person/zhong/
E-Mail:
Interests: women’s health: non invasive prenatal diagnosis and tumor marker’s in gynecologic cancer
Dr. Penghui Zhou
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave., Boston, MA 02115, USA
Tel. +1 617 632 4176
Website: http://connects.catalyst.harvard.edu/profiles/profile/person/97237
E-Mail:
Interests: Cancer immunology; T cell therapy
|
